Stylus Medicine Overview
- Year Founded
-
2022
- Status
-
Private
- Employees
-
48
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$93M
- Investors
-
13
Stylus Medicine General Information
Description
Developer of in vivo genetic medicines designed to enable precise insertion of therapeutic genetic material within the human genome. The company offers engineered recombinase technology, targeted lipid nanoparticle delivery, and gene integration capabilities for complex therapeutic payloads, enabling healthcare and biotechnology researchers to develop treatments for oncology, autoimmune, and genetic diseases.
Contact Information
Website
www.stylusmedicine.comCorporate Office
- 1400 One Kendall Square
- Suite 14-403
- Cambridge, MA 02139
- United States
Corporate Office
- 1400 One Kendall Square
- Suite 14-403
- Cambridge, MA 02139
- United States
Stylus Medicine Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series A) | 13-May-2025 | $93M | Completed | Pre-Clinical Trials | ||
| 2. Accelerator/Incubator | Completed | Pre-Clinical Trials | ||||
| 1. University Spin-Out | 01-Jan-2022 | Completed | Generating Revenue |
Stylus Medicine Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A-1 | ||||||||
| Series A | ||||||||
| Series A-2 | 14,655,938 | $0.000100 | $0.7 | $0.7 | 1x | $0.7 | 9.95% | |
| Series A-1 NV | 9,111,894 | $0.000100 | $0.82 | $0.82 | 1x | $0.82 | 6.19% |
Stylus Medicine Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Stylus Medicine Patents
Stylus Medicine Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026148213-A1 | Lipid-based formulations for delivery of nucleic acids for engineering immune cells | Pending | 06-Jan-2025 | ||
| WO-2026055638-A2 | Large serine recombinases and systems and uses thereof | Pending | 09-Sep-2024 | ||
| WO-2026055638-A3 | Large serine recombinases and systems and uses thereof | Pending | 09-Sep-2024 | ||
| WO-2025265081-A1 | Cgas-sting pathway inhibitors and uses thereof | Pending | 21-Jun-2024 | ||
| AU-2025236202-A1 | Non-viral circular single-stranded dna systems and uses thereof | Pending | 12-Mar-2024 | C12N15/102 |
Stylus Medicine Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Stylus Medicine Investors (13)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Brainstorm Ventures | Venture Capital | Minority | ||
| California Innovation Fund | Venture Capital | Minority | ||
| Chugai Venture Fund | Corporate Venture Capital | Minority | ||
| Dhuna Ventures | Venture Capital | Minority | ||
| Johnson & Johnson JJDC | Corporate Venture Capital | Minority |
Stylus Medicine FAQs
-
When was Stylus Medicine founded?
Stylus Medicine was founded in 2022.
-
Where is Stylus Medicine headquartered?
Stylus Medicine is headquartered in Cambridge, MA.
-
What is the size of Stylus Medicine?
Stylus Medicine has 48 total employees.
-
What industry is Stylus Medicine in?
Stylus Medicine’s primary industry is Drug Discovery.
-
Is Stylus Medicine a private or public company?
Stylus Medicine is a Private company.
-
What is the current valuation of Stylus Medicine?
The current valuation of Stylus Medicine is .
-
What is Stylus Medicine’s current revenue?
The current revenue for Stylus Medicine is .
-
How much funding has Stylus Medicine raised over time?
Stylus Medicine has raised $93M.
-
Who are Stylus Medicine’s investors?
Brainstorm Ventures, California Innovation Fund, Chugai Venture Fund, Dhuna Ventures, and Johnson & Johnson JJDC are 5 of 13 investors who have invested in Stylus Medicine.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
